Evidence map

ArticleJACC. Advances2024

Rivaroxaban vs Vitamin K Antagonist in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease.

Reinhold Kreutz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 38939389